Energy
PrivateWATCHING — TerraPower has won the licensing race (first US commercial-scale advanced-reactor construction permit, Mar 2026, now pouring concrete at Kemmerer) but not the cost race; conviction unlocks only when Unit 1 proves a repeatable $/kW near target with HALEU secured — until then Meta/Sabey are options, not economics, and the untradeable equity plus a quietly valuable Ac-225 isotopes business make this a track-to-first-power watch, not a buy.
Research
The verdict
WATCHING — TerraPower has won the licensing race (first US commercial-scale advanced-reactor construction permit, Mar 2026, now pouring concrete at Kemmerer) but not the cost race; conviction unlocks only when Unit 1 proves a repeatable $/kW near target with HALEU secured — until then Meta/Sabey are options, not economics, and the untradeable equity plus a quietly valuable Ac-225 isotopes business make this a track-to-first-power watch, not a buy.
TerraPower is a privately held advanced-nuclear developer founded in 2008 by Bill Gates and Nathan Myhrvold (with Dr. John Gilleland) out of Intellectual Ventures, headquartered in Bellevue, WA. It is best understood as three businesses stacked on one nuclear-physics platform, not a single reactor bet:
Contract structure. On the Natrium side, revenue is not yet commercial — it is cost-share and pre-payment: DOE's Advanced Reactor Demonstration Program (ARDP) funds up to $2B on a 50/50 match, and Meta pre-funds deployment of its units (Jan 2026 deal, below). The economics of a repeat Natrium — a take-or-pay PPA at a defensible LCOE — do not yet exist; they are the thing Kemmerer must prove.
Upstream inputs → TerraPower → end customer, named at every link (the lens fails if it stays generic):
Verdict on the chain: the fabrication and EPC links are strengthening (Bechtel + HD Hyundai + GE Vernova is a credible industrial spine). The fuel link is the whole ballgame — one Natrium first core (~15–20 MT) is on the order of the entire near-term US HALEU pool DOE has committed to make available (21 MT by Jun 2026). HALEU is not a line item; it is the gate.
Bargaining power: weak vs. its fuel suppliers (it needs HALEU more than Centrus needs any single customer), improving vs. its offtakers (Meta/Sabey chose Natrium's dispatchability), and strong vs. its site/utility partners (Kemmerer is bespoke to it). Durable moats: process/licensing know-how (the NRC docket is a 2-year head start no rival can copy) and capital access. Fragile moats: cost — none of the above matters if the LCOE doesn't pencil (Lens 12/13).
No segments.csv exists (private, pre-revenue on power) — so this is a structural breakdown, not a financial one; every figure ``, unaudited:
| Business line | Stage | Revenue today | The number that matters |
|---|---|---|---|
| Natrium (SFR power) | FOAK under construction | $0 commercial (DOE cost-share + Meta pre-funding only) | Kemmerer $/kW at completion |
| MCFR / MCRE (molten chloride) | Experiment (first fuel Dec 2025) | $0 (DOE $170M cost-share) | Does the fast-salt concept work? |
| TerraPower Isotopes (Ac-225) | Commercial, shipping weekly | Undisclosed but real | Ac-225 output ramp (targeting 75–100×) |
One widely repeated third-party figure claims "TerraPower's revenue is $369.1M" — treat with suspicion: that same source lists a stale 2028 first-power date, and on a pre-commercial reactor developer such a figure can only be DOE cost-share reimbursement plus isotope sales, not power revenue. Flag as not sourced to a primary disclosure. The honest read: power revenue is zero and years away; the only recurring commercial cash is isotopes.
(+private overlay: Lens 5 → Funding & valuation trajectory; Lens 7 → Cap table & comps; Lens 8 → funding/product events; plus a Traction sub-lens.)
Read: the syndicate is a bullish tell — an NVIDIA strategic entry in 2025 signals the AI-power thesis is pulling nuclear capital, and HD Hyundai is a supply-chain-plus-balance-sheet investor. But the undisclosed 2025 valuation is a caution flag: a step-up from $3.8B would normally be trumpeted; silence is consistent with a flat or lightly-up round in a capital-hungry FOAK build. Unverifiable — labeled ``.
No earnings calls (private). Substituting founder/exec communication:
Tone trajectory: more confident on licensing/construction, notably more guarded on cost and fuel. That divergence is the honest signal.
No public multiples exist for TerraPower (private). The useful comp set is the public/near-public SMR cohort — the market's read on what this space is worth:
| Company | Status | Mkt cap / last mark | Regulatory state | Note |
|---|---|---|---|---|
| TerraPower | Private | ~$3.8B (2022 round); 2025 round undisclosed | Construction permit granted; building | Only utility-scale unit under construction |
| Oklo (OKLO) | Public | ~$11.3B, $2.5B cash, no debt | Pre-permit; Aurora ~2027–28 | Largest SMR pure-play by cap; Meta 1.2 GW campus |
| NuScale (SMR) | Public | ~$3.6B | Only NRC design-certified SMR | No firm plant sale yet |
| X-energy (XE) | IPO pending | Draft S-1 filed Mar 2026, ~$300M raise | Pre-permit; TRISO/Xe-100 | Amazon $700M strategic; the near-term IPO comp |
| Kairos Power | Private | n/a | First advanced-reactor construction permit (Hermes, a demo/non-power unit) | Google PPA Aug 2025 |
| GE Vernova (GEV) | Public | Large-cap (multiple n/a) | — | Natrium co-developer; also BWRX-300 |
| Centrus (LEU) | Public | Mid-cap (multiple n/a) | — | HALEU supplier — the pick-and-shovel |
EV/Sales, EV/EBIT, P/E, dividend yield, 5-yr ROE: n/a for the pre-revenue names (and meaningless — the whole cohort trades on option value, not earnings). The signal in the table: the market pays ~$11B for Oklo with no permit while TerraPower — the only one actually building — last priced at $3.8B private. If SMR sentiment holds, a TerraPower IPO would likely price well above its 2022 mark; if it cracks (Lens 13), the whole cohort re-rates together.
The "price-move" analogue for a private is the milestone that re-rates the next round / IPO. Five-year pattern:
Pattern: this name re-rates on regulatory milestones and marquee offtakes, and de-rates on fuel/cost news. The next re-raters: NRC operating-license progress, a secured HALEU contract for the first core, a second confirmed site (Utah), and any move toward an IPO/S-1.
No income statement, balance sheet, or cash-flow statement is public — so classic forensic accounting analysis is not applicable; the analogous private-company risks:
Regulatory findings (required sub-section):
TerraPower is not in research/private-watch.json — so this is web-grounded judgment, and an open item to backfill into that ledger so privates.ts shows it dossier-warm.
(No forecast.ts create in unattended/watchlist mode, and no EPS line exists for a pre-revenue private — the tracked binary, when this graduates to a call, is "Kemmerer Unit 1 reaches first power by YE2031" and "TerraPower discloses a Natrium NOAK target ≤ $X/kW.")
Bull. TerraPower is the only advanced-reactor developer with a utility-scale unit actually under construction — a licensing lead measured in years over NuScale/Oklo/X-energy. Its dispatchable (reactor-plus-battery) product is the best-fit nuclear asset for AI data centers, which is exactly why Meta and NVIDIA showed up in 2025–26. It has >$3.4B committed, a patient billionaire chairman, an industrial spine (Bechtel + GE Vernova + HD Hyundai), a second reactor line (molten chloride, maritime) as free optionality, and a quietly valuable, already-commercial Ac-225 isotopes business the market isn't pricing. If Kemmerer proves even a credible path to NOAK cost-down, TerraPower re-rates hard above its $3.8B private mark.
Bear (permanent-impairment risks). (1) Cost. A tripled FOAK $/kW (~$10B implied) with an unproven NOAK curve is the Vogtle risk in a new package — $35B and 7 years late is the cautionary comp for how new US nuclear actually goes. (2) Fuel. One first core (~15–20 MT HALEU) approaches the entire near-term national HALEU supply; if domestic enrichment slips, first power slips again — as it already did once. (3) Offtakes are options, not contracts. Meta/Sabey are MOUs and pre-funding frameworks; a data-center power buyer can walk if the schedule or price moves.
Pre-mortem (18 months out, thesis broken): it's early 2028, Kemmerer construction has hit a first-of-a-kind cost/schedule wall, the HALEU contract for the first core still isn't delivered, Meta has quietly re-weighted toward its Vistra/Oklo tranches, and the undisclosed 2025 valuation turns out to have been flat — the IPO window closes and the next raise is a down round.
Are multiples too high? There is no TerraPower multiple. But the cohort (Oklo ~$11B, no permit) prices deep option value; TerraPower is the cheapest way to own the most-de-risked asset — which is either a mispricing or a warning that the private mark is stale.
Contrarian view (what the market refuses to see): the consensus story is "AI needs power → nuclear → buy the SMRs." The thing under-appreciated is that TerraPower's isotopes business may de-risk the equity independent of the reactor timeline, and that the permit — not the offtakes — is the asset: it is the one thing no competitor can replicate on any timeline.
Dismantling the bull case: The permit is not a product. A construction permit means TerraPower is allowed to spend $10B finding out whether it can build this economically — Vogtle also had every permit. Revenue concentration is theoretical and lumpy: the "customers" are MOUs (Meta/Sabey) that convert only if the delivered price beats gas-plus-CCS and grid firm power in 2030–32 — a bar a tripled-cost FOAK may not clear. The moat may be weaker than bulls think: GE Vernova (a Natrium co-developer) also sells the light-water BWRX-300, and Kairos already has Google's money and a construction permit of its own — TerraPower's lead is in one technology lane, and sodium's "ignites on contact with air/water" handling burden is a permanent cost penalty. Worst capital-allocation/governance signal: the undisclosed 2025 valuation plus the Gates/Myhrvold/Epstein-ties reporting are exactly the disclosure-quality and headline-risk items a short would press. What must hold for today's ~$3.8B mark: that FOAK cost-down to a competitive NOAK is real, that HALEU shows up on time, and that hyperscaler MOUs become priced PPAs. If growth/timeline disappoints 20–30% (first power slips to 2033+, one more HALEU delay), the private mark is stale and the next raise is down. Single permanent-impairment scenario: a first-of-a-kind sodium-systems failure or cost blowout at Kemmerer that makes NOAK uneconomic — plausible enough (this is genuinely unproven at scale in the West) to keep this a watch, not a buy.
Research Trail
Covered in the Knowledge Base
Energy
The most physically elegant fusion bet per dollar — a no-magnet, no-laser Z-pinch ~9x more capital-efficient than the tokamak leaders — but the April-2026 fission pivot is the tell: Zap is now a near-term fission-revenue company wearing a fusion halo. Underwrite the falsifiable milestones (independently-verified Q≥1 at ~650 kA; a signed 4S/fission milestone contract), not the 2030s grid dream. WATCHING · MEDIUM.
The cleanest listed way to own physical uranium at a discount — at ~527p the market prices YCA's U3O8 near ~$70/lb vs ~$85 spot and ~$91.50 term; the discount, not a uranium view, is the edge. It closes if the buyback + a firm spot bid hold; the thesis breaks if uranium rolls over or the ~15% structural discount becomes permanent. This is levered beta to one variable with a fee lid, not an operating business.